Evidence map›Paper›PMID 23771688›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2013

Angiotensin receptor-mediated oxidative stress is associated with impaired cardiac redox signaling and mitochondrial function in insulin-resistant rats.

José Pablo Vázquez-Medina, Irina Popovich, Max A Thorwald, Jose A Viscarra, Ruben Rodriguez, Jose G Sonanez-Organis, Lisa Lam, Janos Peti-Peterdi, Daisuke Nakano, Akira Nishiyama and 1 more

Abstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 62 citations in OpenAlex.

  1. Antioxidants supplementation in elderly cardiovascular patients.Oxidative medicine and cellular longevity · 2013
    Trial
  2. Review
  3. Review
  4. Mitochondrial Dysfunction in HFpEF: Potential Interventions Through Exercise.Journal of cardiovascular translational research · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

José Pablo Vázquez-MedinaDepartment of Molecular and Cellular Biology, School of Natural Sciences, University of California Merced, Merced, California;
Irina Popovich
Max A Thorwald
Jose A Viscarra
Ruben Rodriguez
Jose G Sonanez-Organis
Lisa Lam
Janos Peti-Peterdi
Daisuke Nakano
Akira Nishiyama
Rudy M Ortiz
University of California, Merced · USKagawa University · JPUniversity of Southern California · US

Funding

UCSC MHIRT Research Training GrantT37MD001480 · NIMHD · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI ORTIZ, CHARLES L · 2005 to 2018
$3.4M
Mechanisms of Oxidative Stress and Inflammation during Prolonged Fasting and SleeR01HL091767 · NHLBI · UNIVERSITY OF CALIFORNIA, MERCED · PI ORTIZ, RUDY M · 2009 to 2013
$1.9M
Independent Scientist Development Award in Oxidative Stress and ApneaK02HL103787 · NHLBI · UNIVERSITY OF CALIFORNIA, MERCED · PI ORTIZ, RUDY M · 2010 to 2013
$415k
NHLBI NIH HHS K02 HL-103787NHLBI NIH HHS R01 HL-091767NHLBI NIH HHS R01 HL091767NIMHD NIH HHS T37 MD-001480NIMHD NIH HHS T37 MD001480
6 · The paper itself

Abstract

Activation of angiotensin receptor type 1 (AT1) contributes to NADPH oxidase (Nox)-derived oxidative stress during metabolic syndrome. However, the specific role of AT1 in modulating redox signaling, mitochondrial function, and oxidative stress in the heart remains more elusive. To test the hypothesis that AT1 activation increases oxidative stress while impairing redox signaling and mitochondrial function in the heart during diet-induced insulin resistance in obese animals, Otsuka Long Evans Tokushima Fatty (OLETF) rats (n = 8/group) were treated with the AT1 blocker (ARB) olmesartan for 6 wk. Cardiac Nox2 protein expression increased 40% in OLETF compared with age-matched, lean, strain-control Long Evans Tokushima Otsuka (LETO) rats, while mRNA and protein expression of the H₂O₂-producing Nox4 increased 40-100%. ARB treatment prevented the increase in Nox2 without altering Nox4. ARB treatment also normalized the increased levels of protein and lipid oxidation (nitrotyrosine, 4-hydroxynonenal) and increased the redox-sensitive transcription factor Nrf2 by 30% and the activity of antioxidant enzymes (SOD, catalase, GPx) by 50-70%. Citrate synthase (CS) and succinate dehydrogenase (SDH) activities decreased 60-70%, whereas cardiac succinate levels decreased 35% in OLETF compared with LETO, suggesting that mitochondrial function in the heart is impaired during obesity-induced insulin resistance. ARB treatment normalized CS and SDH activities, as well as succinate levels, while increasing AMPK and normalizing Akt, suggesting that AT1 activation also impairs cellular metabolism in the diabetic heart. These data suggest that the cardiovascular complications associated with metabolic syndrome may result from AT1 receptor-mediated Nox2 activation leading to impaired redox signaling, mitochondrial activity, and dysregulation of cellular metabolism in the heart.

Indexed as

Insulin ResistanceOxidative StressSignal TransductionAldehydesAngiotensin II Type 1 Receptor BlockersAnimalsCatalaseCitrate (si)-SynthaseDisease Models, AnimalGene Expression Regulation, EnzymologicGlutathione PeroxidaseImidazolesMaleMembrane GlycoproteinsMitochondria, HeartMyocardium3-nitrotyrosine4-hydroxy-2-nonenalAldehydesAngiotensin II Type 1 Receptor BlockersCatalaseCitrate (si)-SynthaseCybb protein, ratGlutathione PeroxidaseImidazolesMembrane GlycoproteinsNADPH Oxidase 2NADPH Oxidase 4NADPH OxidasesNfe2l2 protein, ratNF-E2-Related Factor 2Nox4 protein, ratolmesartanReceptor, Angiotensin, Type 1RNA, MessengerSuccinate DehydrogenaseSuperoxide DismutaseTetrazolesTyrosinemetabolic syndromeNADPH oxidaseNrf2

Identifiers

PMID23771688
PMCPMC3891241
OpenAlexW2151331695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.